←
PolyBio2,984 posts
PolyBio avatar

PolyBio

@polybioRF

501(c)3 transforming how LongCovid, ME/CFS, Lyme+ and Alzheimer’s are studied, diagnosed, and treated. Leading the #LongCovid Research Consortium.

◷ Joined October 2020▧ 792 Photos and videos
PolyBio avatar
PolyBio@polybioRF·1 Nov 2025

From Crisis to Cure: PolyBio is supporting top HIV researchers to pivot into the study and treatment of Long COVID. Watch the full video to learn how this collaboration is being maximized & driving forward innovative research: youtu.be/6kC1lyY6hPc?si=adTg…

Post attachment
PolyBio avatar
PolyBio@polybioRF·Nov 18

TOMORROW—PolyBio’s inaugural Convergence Summit kicks off at 8:30 am EST with Scientific Director Dr. Amy Proal’s welcome address. She’ll highlight the main theme of the conference—pathogen persistence—and the new frontier it presents for chronic disease and aging. Join information: polybio.org/virtual-summit/

Post attachment
PolyBio avatar
PolyBio@polybioRF·Nov 16

Discussions will focus on the practical challenges that must be addressed to translate discoveries into validated diagnostics, clinical trials, and effective therapies for IACIs. Full schedule: polybio.org/wp-content/uploa…

PolyBio avatar
PolyBio@polybioRF·Nov 16

This Wednesday, November 18th: PolyBio’s inaugural Convergence Summit kicks off at the American Academy of Arts & Sciences, with 3 days of live-streamed presentations highlighting the role of pathogens in chronic diseases. You’ll hear about the latest advances in Long COVID, multiple sclerosis, neurodegenerative disease, autoimmune disorders, and the biological processes underlying aging. Join information: polybio.org/virtual-summit/

2:04
PolyBio avatar
PolyBio@polybioRF·Nov 14

Across the three days, presentations will run on one continuous pathway from the underlying biology of pathogen persistence; to detection, novel therapeutics, and scaling up healthcare innovations in infection-associated chronic diseases via public-private partnerships. Full schedule: polybio.org/wp-content/uploa…

PolyBio avatar
PolyBio@polybioRF·Nov 14

PolyBio’s inaugural Convergence Summit is coming up this Wednesday, November 18th to Friday, November 20th! Presentations will explore the latest advances in persistent infections and their emerging roles in conditions such as Long COVID, multiple sclerosis, neurodegenerative disease, autoimmune disorders, and the biological processes underlying aging. Join information: polybio.org/virtual-summit/

Post attachment
PolyBio avatar
PolyBio@polybioRF·Nov 11

PolyBio’s inaugural Convergence Summit 2026 is fast approaching! From November 18 to 20, presentations will address evolving research on the relationship between pathogens and chronic diseases such as Long COVID, chronic Lyme disease, MS, Alzheimer’s, and more. The meeting will bring together leading researchers, clinicians, biotech innovators and public health experts to address the rapid need for IACI diagnostics and treatments to translate from the lab bench to hospital bedside.

2:52
PolyBio avatar
PolyBio@polybioRF·Nov 6

Featured on @WCVB last night: PolyBio’s Scientific Director Dr. Amy Proal and PolyBio funder and collaborator Steve Pagliuca. They highlighted the impact of Long COVID on patients’ quality of life—and how PolyBio’s research programs are rapidly validating tissue and biofluid-based diagnostic tests that will fill gaps in clinical care.

2:41
PolyBio avatar
PolyBio@polybioRF·Nov 3

The final summit day on November 20th will focus on treatment of acute infections to prevent chronic illness, innovative technologies in persistence research, and genetic/viral retroelements in chronic disease.

Post attachment
PolyBio avatar
PolyBio@polybioRF·Nov 3

Presentations on November 19th will address how we can optimize clinical trials to control persistent infection, how infections contribute to aging and mitochondrial dysfunction, and best practices for clinical care for people with IACCIs.

Post attachmentPost attachment
PolyBio avatar
PolyBio@polybioRF·Nov 3

Presentations on November 18th will focus on pathogen persistence in Infection-Associated Chronic Disease, next-generation diagnostic tests to detect persistence, and innovative treatments that support immune function.

Post attachmentPost attachment
PolyBio avatar
PolyBio@polybioRF·Nov 3

We’re pleased to announce the inaugural PolyBio Convergence Summit will take place this November 18 to 20. Presentations will explore the latest advances in persistent infections and their emerging roles in conditions such as Long COVID, chronic Lyme disease, multiple sclerosis, Alzheimer’s, and aging. Discussions will focus on the practical challenges that must be addressed to translate these discoveries into validated diagnostics, clinical trials, and effective therapies. Add the virtual schedule to your calendar here: calendar.google.com/calendar…

Post attachment
PolyBio avatar
PolyBio@polybioRF·Oct 30

Eligibility criteria: • You have a clinical diagnosis of chronic Lyme disease or post-treatment Lyme disease • You have a clinical diagnosis of neuropathic pain • You are 18 years or older • You live in the United States and are able to attend virtual visits If interested, please reach out to CoreResearch@MountSinai.org to apply. *Note that this is a randomized study with a 1:1 ratio of participants assigned to the treatment versus sham control. clinicaltrials.gov/study/NCT…